Insulin resistance in women with recurrent spontaneous miscarriage of unknown aetiology

Medical Principles and Practice

Volumn 16, Issue 2, 2007, Pages 114-118

  Diejomaoh, Michael ^a,b   Jirous, Jiri ^b   Al Azemi, Majedah ^a,b   Gupta, Madhu ^b   Al Jaber, Manal ^b   Farhat, Rasheeda ^b   Mohd, Asiya ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL SABAH HOSPITAL   (Kuwait)

Author keywords

Insulin; Insulin, resistance; Miscarriage; Miscarriage, recurrent

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ETHNICITY; FEMALE; FEMALE FERTILITY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; PARITY; RECURRENT DISEASE; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN RESISTANCE;

EID: 33847022574     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098363     Document Type: Article

References (28)

1. Diejomaoh M, Jirous J, Al-Azemi M, Baig S, Gupta M, Tallat A: The relationship of recurrent spontaneous miscarriage to reproductive failure. Med Princ Pract 2003;12:107-111.
2. Kutteh WH: Recurrent pregnancy loss; in Carr BR, Blackwell RE (eds): Textbook of Reproductive Medicine, ed 2. Stamford, Appleton & Lange, 1998, pp 679-692.
3. Craig LB, Ke RW, Kutteh WH: Increased prevalence of insulin resistance in women with history of recurrent pregnancy loss. Fertil Steril 2002;78:487-490.
4. Diejomaoh MFE, Al-Azemi M, Jirous J, Bander A, Egbase P, Al-Sweih N, Al-Othman S: The aetiology and pattern of recurrent pregnancy loss. J Obstet Gynaecol 2002;22:62-67.
5. Diejomaoh MF, Al-Azemi M, Bander A, Egbase PE, Jirous J, Al-Othman S, Bukhadour N, Al-Sweih N: A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome. Arch Gynecol Obstet 2002;266:61-66.
6. Clifford K, Rai R, Watson H, Reagen L: An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994;9:1328-1332.
7. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 1989;38:1165-1174.
8. Royal College of Obstetricians and Gynaecologists (RCOG): The Management of Recurrent Miscarriage. Guidelines No.17. London, RCOG, 1998, pp1-10.
9. Ehrmann DA, Sturis J, Bryne MM, Harrison T, Rosenfield RL, Polansky KS: Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 1995;96:520-527.
10. Apter D, Butzow T, Langhlin GA, Yen SS: Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995;80:2966-2973.
11. Velasquez E, Mendosa SG, Wang O, Glueck CJ: Metformin therapy is associated with decrease in plasma activator inhibitor-1, lipoprotein (a) and immunoreactive insulin levels in patients with polycystic ovary syndrome. Metabolism 1997;46:454-457.
12. Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Tracy T, Moore SK: Plasminogen inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovarian syndrome. Metabolism 1999;48:1589-1595.
13. Glueck CJ, Wang P, Sieve-Smith L, Fontaine RN, Tracy T: Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrhoeic women with polycystic ovarian syndrome. Metabolism 1999;48:511-519.
14. Sampson M, Kong C, Patel A, Unwin R, Jacobs HS: Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) in lean women with and without polycystic ovary syndrome. Clin Endocrinol 1996;45:623-629.
15. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P: Continuing metformin throughout pregnancy in women with polycystic ovarian syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001;75:46-52.
16. Gris JC, Ripart-Neveu S, Mangard S, Thailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Mares P: Prospective evaluation of the prevalence of haemostatic abnormalities in unexplained primary early recurrent miscarriages: the Nimes Obstetricians and Haematologists (NOHA) study. Thromb Haemost 1997;77:1096-1103.
17. Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF: Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993;122:606-615.
18. Legro RS, Finegood D, Dunaif A: A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-2698.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment :insulin resistance and β-cell function from fasting glucose and insulin concentrates in men. Diabetologia 1985;28:412-419.
20. Kauffman RP, Castracane D: Assessing insulin sensitivity. Contemp Ob Gyn 2003;48:30-48.
21. Defronzo RA, Tobin JD, Andres R: Glucose clamp techniques: a method of quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214.
22. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz M, Quon J, Baron AD: Repeatability characteristics of simple incidences of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001;86:5457-5464.
23. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
24. Carmina E, Lobo RA: Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004;82:661-665.
25. Williamson K, Gunn AJ, Johnson N: The impact of ethnicity on the presentation of polycystic ovarian syndrome. Obstet Gynecol 2001;41:202-206.
26. Wijeyaratne CN, Balen AH, Barth JH: Clinical manifestations of insulin resistance (IR) in polycystic ovarian syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol 2002;57:343-350.
27. Avellone G, Di Garbo V, Cordova R, Rotolo G, Abruzzese G, Raneli G, De Simone R, Bompiani GD: Blood coagulation and fibrinolysis in obese NIDDM patients. Diabetes Res 1994;25:85-92.
28. Atiomo WU, Bates SA, Condon JE, Shaw S, West JH, Prentice AG: The plasminogen activator system in women with polycystic ovary syndrome. Fertil Steril 1998;69:236-241.